Skip to main content

Thoracic Pathology



Evaluated by: 
David B. Kaminsky, MD, FIAC, October 24, 2018
Original release date: December 12, 2018
Access to this course expires on:  October 24, 2021, at 11:59 PM Pacific Time
CME 14.75

Course Description

Thoracic specimens are commonly encountered in clinical practice derived from biopsy and surgical procedures on pulmonary, cardiovascular and mediastinal tissue. The panorama includes neoplasms and non-neoplastic entities. The fact that many of these require evaluation for medical diseases of the thorax provokes anxiety among pathologists, particularly where subspecialty pathologists are not readily available. The last five years contributed a dizzying array of updates in classification, nomenclature and reporting guidelines. Therefore, it’s time for pathologists to update their knowledge and skills in the diagnosis of thoracic pathology in an intimate mentoring environment that unites experienced experts with pathologists desiring a contemporary review of modern thoracic pathology.

Target Audience
Practicing academic and community pathologists, and pathologists-in-training

Learning Objectives
Upon completion of this educational activity, learners will be able to:
  • Understand the fundamental approaches to handling thoracic specimens
  • Apply and recognize new classification/grading schemes regarding thoracic disease
  • Recognize the importance of multidisciplinary (i.e., radiologic) collaboration in thoracic disease
  • Identify clinically relevant diagnostic concepts to aid in patient management
  • Utilize appropriate and minimum ancillary studies to diagnose and/or exclude lymphoproliferative processes

Continuing Medical Education
The United States and Canadian Academy of Pathology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The United States and Canadian Academy of Pathology designates this enduring material for a maximum of 14.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Beginning in 2021, the American Board of Pathology (ABPath) will no longer require Self-Assessment Modules (SAMs) for Part II Lifelong Learning of the Continuing Certification program. For additional information, visit the ABPath website.


Disclosures
The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to USCAP and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. USCAP has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships: Joseph J. Maleszewski, MD, Marie-Christine Aubry, MD, Jennifer M. Boland, MD, Paul J. Kurtin, MD, Anja C. Roden, MD  

The following IM Coordinators reported no relevant financial relationships: David B. Kaminsky, MD, FIAC, Laura Lamps, MD and Steven D. Billings, MD USCAP staff associated with the development of content for this activity reported no relevant financial relationships.

To earn CME credit, all learners must complete the evaluation. Your certificate will be available to view and print by  clicking here.

Buy the entire Thoracic Pathology course and get a great discount!

Not A Member? Click Here